A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation

BACKGROUND: Thrombocytopenia represents an obstacle for invasive procedures in chronic liver disease (CLD) patients. We aimed to estimate the appropriate dose and evaluate the efficacy and safety of lusutrombopag for the treatment of thrombocytopenia before percutaneous liver radiofrequency ablation...

Descripción completa

Detalles Bibliográficos
Autores principales: Tateishi, Ryosuke, Seike, Masataka, Kudo, Masatoshi, Tamai, Hideyuki, Kawazoe, Seiji, Katsube, Takayuki, Ochiai, Toshimitsu, Fukuhara, Takahiro, Kano, Takeshi, Tanaka, Katsuaki, Kurokawa, Mineo, Yamamoto, Kazuhide, Osaki, Yukio, Izumi, Namiki, Imawari, Michio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2018
Materias:
Original Article—Liver, Pancreas, and Biliary Tract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349796/
https://www.ncbi.nlm.nih.gov/pubmed/30105510
http://dx.doi.org/10.1007/s00535-018-1499-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349796/
https://www.ncbi.nlm.nih.gov/pubmed/30105510
http://dx.doi.org/10.1007/s00535-018-1499-2

Ejemplares similares